klinische pädiatrie
130330
DE
EN
Home
Products
Journals
Books
Book Series
Service
Library Service
Help
Contact
Portal
Klinische Pädiatrie
Full-text search
Full-text search
Author Search
Title Search
DOI Search
Metadata Search
Journal
More About This Journal
Editorial Board
Table of Contents
German National License
Imprint
Media
Authors
Instructions for Authors
Submit a Manuscript
Subscription
Subscription Information & Contacts
Institutional Licensing
Job Board
Job Opportunities
PharmaMarket
PharmaMarket
Not Logged In
Login
Username or e-mail address:
Password:
Forgot Access Data?
Register Now
OpenAthens/Shibboleth Login
Shopping Cart
Year (Archive)
2024
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1989
1988
1987
1986
1985
1984
1983
1982
1981
1980
Issues
Current Issue
Free Sample Issue (01/2024)
Related Books
Pädiatrie
13th Expert Meeting for Pediatric Oncology and Hematology
Abstracts (HTML)
List of Authors
A
B
C
D
E
F
G
H
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Z
Aryee, D
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Astrahantseff, K
Molecular Targets in Embryonal Tumors
Bader, P
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Ban, J
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Benetkiewicz, M
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Berthold, F
Novel Targeted Agents in Neuroblastoma
Binder, V
Hsa-mir-125b-2 is Highly Expressed in Childhood ETV6/RUNX1 (TEL/AML1) Leukemias and Confers Survival Advantage to Growth Inhibitory Signals Independent of P53
Borkhardt, A
The Expanding Family of ALK-Mediated Malignancies in Childhood
Bourquin, JP
Xenotransplantation in Immunodeficient Mice to Evaluate New Therapeutic Strategies for Refractory Childhood Acute Lymphoblastic Leukemia
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Breit, S
The Role of Activated NOTCH Signaling in Childhood T-ALL
Breithaupt, P
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Brown, R
Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience
Bueren, AO von
Molecular-Targeted Therapies for Childhood Medulloblastoma
Burdach, S
Targeting Epigenetic Maintenance of Stemness in Pediatric Malignancy
Cam, H
Dysregulation of mTORC1 Signaling in Childhood Solid Tumors
Cario, G
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Caron, HN
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Clifford, S
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Clifford, SC
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Conter, V
Clinical Goals of Targeted Therapy in Childhood ALL
Corbacioglu, S
The RIST Strategy: Molecular-Based Multimodal Treatment Regimens in Pediatric Oncology
Debatin, KM
Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups
Cell Death Pathways: Sensitivity and Resistance in Leukemia
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
Degrand, O
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
De Jong, S
Targeting TRAIL Death Receptors: TRAIL from the Lab to the Clinic
Delattre, O
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Den Boer, M
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Den Boer, ML
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Deubzer, H
Targeting HDACs in Pediatric Oncology
De Vries, EGE
Targeting TRAIL Death Receptors: TRAIL from the Lab to the Clinic
Ecke, I
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Eckhoff, SM
Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups
Eggert, A
Molecular Targets in Embryonal Tumors
Ehrhardt, H
NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs
Fakler, M
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
Fischer, M
Novel Targeted Agents in Neuroblastoma
Fulda, S
Targeting Apoptosis Pathways for the Treatment of Pediatric Cancers
Editorial
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
Geoerger, B
Innovative Therapies for Children with Cancer (ITCC): Clinical Trial Program
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Gombert, M
High-Throughput Mutation Analysis of Tyrosine Kinome in Childhood AML
Hahn, H
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Helman, LJ
Targeting the IGF1 Pathway in Pediatric Sarcomas
Herold, R
Regulatory and Scientific Support for Developing Innovative Medicines for Children with Cancer
Höfig, I
NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs
Holst, M
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Houghton, PJ
Development of Novel Therapy for Childhood Cancer: Promise and Challenges
Dysregulation of mTORC1 Signaling in Childhood Solid Tumors
Jaeger, BAS
Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)
Jeremias, I
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs
Jug, G
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Kappler, R
The Hedgehog Signaling Pathway as a Therapeutic Target in Pediatric Liver Tumors
Kauer, M
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Klingebiel, T
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Koehl, U
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Kool, M
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Kovar, H
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Kox, C
The Role of Activated NOTCH Signaling in Childhood T-ALL
Kreyenberg, H
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Kuçi, S
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Kuçi, Z
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Kulozik, AE
The Role of Activated NOTCH Signaling in Childhood T-ALL
Künkele, A
Molecular Targets in Embryonal Tumors
Lanvers, C
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Letai, A
BH3 Profiling – A Predictive Biomarker for Apoptotic Response to Chemotherapy
Löder, S
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
Mann, G
Clinical Goals of Targeted Therapy in Childhood ALL
Meissner, B
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Mesdagh, P
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Meyer, LH
Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups
Milde, T
Targeting HDACs in Pediatric Oncology
Molenaar, JJ
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Möricke, A
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Muckenthaler, MU
The Role of Activated NOTCH Signaling in Childhood T-ALL
Niedan, S
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Nitzki, F
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Obexer, P
NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs
Oehme, I
Targeting HDACs in Pediatric Oncology
Pajtler, K
Molecular Targets in Embryonal Tumors
Pfister, S
Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience
Potential of Molecular Targeted Therapies in Childhood Brain Tumors (BRAF Inhibitors)
Pieters, R
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Pietsch, T
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Poremba, C
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Potratz, J
RNA Interference Screening to Identify Novel Therapeutic Targets
Queudeville, M
Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups
Raymond, AS
Regulatory and Scientific Support for Developing Innovative Medicines for Children with Cancer
Remke, M
The Role of Activated NOTCH Signaling in Childhood T-ALL
Renshaw, J
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Rettinger, E
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Ritter, J
The Etiology of Acute Childhood Leukemias
Rosenberger, A
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Rosen-Wolff, A
Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)
Rutkowski, S
Molecular-Targeted Therapies for Childhood Medulloblastoma
Schäfer, BW
Therapeutic Strategies Targeting Oncogenic Fusion Proteins in Sarcomas
Schneider, K
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
Schramm, A
Molecular Targets in Embryonal Tumors
Schrappe, M
The Role of Activated NOTCH Signaling in Childhood T-ALL
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Schrauder, A
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Schulte, JH
Lysine-Specific Demethylase 1 is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
Molecular Targets in Embryonal Tumors
Schulz-Schaeffer, W
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Scotlandi, K
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Segers, S
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Serra, M
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Shipley, J
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Sorensen, P
RNA Interference Screening to Identify Novel Therapeutic Targets
Tyrosine Kinase Networks in Pediatric Cancer
Speleman, F
The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma
Stanulla, M
The Role of Activated NOTCH Signaling in Childhood T-ALL
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach
Stroeken, PJ
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Suttorp, M
Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)
Tauer, JT
Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)
Terziyska, N
NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs
Thall, P
Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience
Uhmann, A
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Valsecchi, MG
Clinical Goals of Targeted Therapy in Childhood ALL
Vassal, G
Innovative Therapies for Children with Cancer (ITCC): Clinical Trial Program
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Verschuur, AC
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Versteeg, R
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Vogler, M
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
Von Laer, D
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Warps, R
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
Weber, G
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Westerhout, EM
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors
Willasch, A
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Witt, O
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Targeting HDACs in Pediatric Oncology
Wolff, JE
Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience
Zibat, A
Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Zimmermann, M
The Role of Activated NOTCH Signaling in Childhood T-ALL
Clinical Goals of Targeted Therapy in Childhood ALL